Skip to main
ASXC
ASXC

Asensus Surgical (ASXC) Stock Forecast & Price Target

Asensus Surgical (ASXC) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Asensus Surgical Inc. demonstrates a robust outlook due to the significant growth of surgical procedures, with over 3,550 performed in 2023, reflecting a 13% year-over-year increase. The company's investments in research and development, amounting to $9.3 million and a 39% increase year-over-year, indicate a commitment to innovation and long-term growth potential through new product offerings like LUNA and the Intelligent Surgical Unit. Additionally, the anticipated expansion of the Senhance programs in 2024, along with the projected 15%-20% growth in procedure volume, highlights a favorable market positioning within a substantial $56 billion global opportunity in laparoscopic surgeries.

Bears say

Asensus Surgical Inc reported total revenues of $5.4 million for 4Q23, slightly below the consensus estimate of $5.5 million, and experienced a net loss of $0.07 per share, conforming to expectations, which highlights challenges in meeting growth targets. The company revised its Senhance placements guidance down to 8-10 units for 2023, signaling potential struggles in market penetration and product adoption, particularly amidst a tough economic environment and increasing competition in the surgical robotics sector. Additionally, the significant reduction in revenue estimates to $6.8 million from $8.0 million, compounded by concerns over liquidity and a lack of visibility into the company's future financial performance, supports a cautious outlook.

Asensus Surgical (ASXC) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Asensus Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Asensus Surgical (ASXC) Forecast

Analysts have given Asensus Surgical (ASXC) a Hold based on their latest research and market trends.

According to 2 analysts, Asensus Surgical (ASXC) has a Hold consensus rating as of Jul 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $0.68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $0.68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Asensus Surgical (ASXC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.